Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

Diagnosing, treating and managing breast cancer during COVID-19

COVID-19: Risk of millions relapsing back to smoking

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms

The COVID-19 and Cancer Consortium

A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic

Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?

Treatment of cancer patients during the COVID-19 pandemic in the Philippines